$9.11
2.82%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
VGG7185A1286
Symbol
PRTG

Portage Biotech Inc Stock price

$9.11
+3.28 56.37% 1M
+4.52 98.26% 6M
+3.94 76.21% YTD
+6.41 237.37% 1Y
-141.89 93.97% 3Y
-200.89 95.66% 5Y
-290.89 96.96% 10Y
-2,930.89 99.69% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.25 2.82%
ISIN
VGG7185A1286
Symbol
PRTG
Industry

Key metrics

Basic
Market capitalization
$20.8m
Enterprise Value
$19.0m
Net debt
positive
Cash
$1.8m
Shares outstanding
1.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
- | -
EV/Sales
- | -
EV/FCF
negative
P/B
14.8
Financial Health
Equity Ratio
51.7%
Return on Equity
-1,873.2%
ROCE
-639.0%
ROIC
-1,493.4%
Debt/Equity
0.0
Financials (TTM | estimate)
Revenue
$0.0 | $0.0
EBITDA
$-11.7m | -
EBIT
$-11.8m | $-16.7m
Net Income
$-67.3m | $-590.0k
Free Cash Flow
$-9.8m
Growth (TTM | estimate)
Revenue
- | -
EBITDA
90.9% | -
EBIT
90.8% | 8.2%
Net Income
40.5% | 99.2%
Free Cash Flow
35.2%
Margin (TTM | estimate)
Gross
-
EBITDA
- | -
EBIT
-
Net
- | -
Free Cash Flow
-
More
EPS
$-62.5
FCF per Share
$-8.7
Short interest
4.3%
Employees
4
Rev per Employee
$0.0
Show more

Is Portage Biotech Inc a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,019 stocks worldwide.

Portage Biotech Inc Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Portage Biotech Inc forecast:

3x Hold
50%
3x Sell
50%

Analyst Opinions

6 Analysts have issued a Portage Biotech Inc forecast:

Hold
50%
Sell
50%

Financial data from Portage Biotech Inc

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
- -
-
100%
- Direct Costs - -
-
-
- -
-
-
- Selling and Administrative Expenses 5.02 5.02
29% 29%
-
- Research and Development Expense 6.70 6.70
47% 47%
-
-12 -12
91% 91%
-
- Depreciation and Amortization 0.04 0.04
33% 33%
-
EBIT (Operating Income) EBIT -12 -12
91% 91%
-
Net Profit -67 -67
40% 40%
-

In millions USD.

Don't miss a Thing! We will send you all news about Portage Biotech Inc directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Portage Biotech Inc Stock News

Neutral
GlobeNewsWire
about one month ago
DOVER, Del., July 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands, with a portfolio of novel multi-targeted therapies for use as monotherapy and in combination, today reported its financial results for the fiscal year ended March 31, 2025.
Neutral
GlobeNewsWire
2 months ago
DOVER, Del., June 25, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (“Portage” or the “Company”) (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”), announced today that on June 24, 2025, the Company received formal notice from The Nasdaq Stock Market LLC that the Company has evidenced compliance with all applicable requireme...
Neutral
GlobeNewsWire
3 months ago
DOVER, Del., June 09, 2025 (GLOBE NEWSWIRE) -- Portage Biotech Inc. (NASDAQ: PRTG), a clinical-stage immuno-oncology company formed under the laws of the British Virgin Islands (“Portage”) announce that on June 5, 2025 Portage and Compedica Holdings Limited, a company formed under the laws of the Isle of Man (“Compedica”) entered a mutual Subscription Agreement (“Subscription Agreement”).
More Portage Biotech Inc News

Company Profile

Portage Biotech, Inc. is a biotechnology company, which enables research and development to produce clinical programs and maximize potential returns. Its portfolio includes subsidiary companies, whose products or technologies have established scientific rationales, including intratumorals, nanoparticles, liposomes, aptamers, cell penetrating peptides, and virus-like particles. The firm provides funding, strategic business and clinical counsel, and shared services to treat different types of cancers. The company was founded by Gregory H. Bailey in 1973 and is headquartered in Road Town, British Virgin Islands.

Head office Virgin Islands, British
CEO Alexander Pickett
Employees 4
Founded 1973
Website portagebiotech.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today